Periscope Capital’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Periscope Capital’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-531,600	Closed	-$5.25M	–	1084
2022 Q3	$5.25M	Sell	531,600 -200	-0%	-$1.97K	0.15%	265
2022 Q2	$5.22M	Buy	531,800 +596	+0.1%	+$5.85K	0.14%	299
2022 Q1	$5.2M	Buy	531,204 +130,204	+32%	+$1.27M	0.13%	305
2021 Q4	$3.93M	Sell	401,000 -400	-0.1%	-$3.9K	0.11%	375
2021 Q3	$3.91M	Hold	401,400	–	–	0.12%	333
2021 Q2	$3.88M	Buy	+401,400	New	+$3.9M	0.13%	324

Periscope Capital's SHAC Position: Q4 2022 in Review

Periscope Capital sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 531,600 shares — an estimated $5.25M sold.

Periscope Capital first reported a position in SHAC in Q2 2021 and held it in 6 quarters. The position peaked at $5.25M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Periscope Capital reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Periscope Capital sold 531,600 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $5.25M.
Periscope Capital first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 6 quarters.
Periscope Capital's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $5.25M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Periscope Capital's 13F filing for Q4 2022, filed 13 Feb 2023.